Correlation Between Biofil Chemicals and Goldman Sachs

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Goldman Sachs Group, you can compare the effects of market volatilities on Biofil Chemicals and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Goldman Sachs.

Diversification Opportunities for Biofil Chemicals and Goldman Sachs

0.04

Correlation Coefficient

Biofil Chemicals  Goldman Sachs

Significant diversification

The 3 months correlation between Biofil and Goldman is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Goldman Sachs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Group and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Group has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Goldman Sachs go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Goldman Sachs

Assuming the 90 days trading horizon Biofil Chemicals is expected to generate 10.43 times less return on investment than Goldman Sachs. In addition to that, Biofil Chemicals is 2.25 times more volatile than Goldman Sachs Group. It trades about 0.01 of its total potential returns per unit of risk. Goldman Sachs Group is currently generating about 0.23 per unit of volatility. If you would invest  40,807  in Goldman Sachs Group on February 5, 2024 and sell it today you would earn a total of  3,011  from holding Goldman Sachs Group or generate 7.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	86.36%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  Goldman Sachs Group

Biofil Chemicals Pha

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound forward indicators, Biofil Chemicals is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Goldman Sachs Group

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Goldman Sachs Group are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Goldman Sachs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Biofil Chemicals and Goldman Sachs

The main advantage of trading using opposite Biofil Chemicals and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.

The idea behind Biofil Chemicals Pharmaceuticals and Goldman Sachs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.